
Corteva Inc (CTVA) Stock Forecast & Price Target
Corteva Inc (CTVA) Analyst Ratings
Bulls say
Corteva is supported by a strong crop protection franchise, a broad global footprint, and differentiated R&D that has already produced 400+ new products annually, with new crop protection launches and biologicals expected to lift sales above market growth. The company’s cost discipline is also compelling, with merger-related synergies of $1.2B in 2021 and run-rate savings of about $750M by 2027, helping offset tariff, inflation, and some near-term pricing pressure. Even with guided FY26 EBITDA of $1.10B-$1.25B, its underlevered balance sheet, strong cash generation, and exposure to improving farmer economics in North America and Latin America support a constructive long-term view.
Bears say
Corteva is facing a fundamentally challenged backdrop as weaker crop prices, elevated corn stocks-to-use of about 15% versus a 10-year average near 12%, and expected 4-5% market declines in 2026 pressure farmer economics and spending on crop protection. The company’s own investor-day framework assumes a 1% annual price decline during 2027-2029, while continued destocking in Latin America, generic deflation, and slower-than-expected new product monetization could keep margins under pressure and limit EBITDA recovery. A smaller standalone portfolio after the 2026 spin of Vylor also may weaken negotiating leverage with large customers, especially in Brazil, while delays in synergy realization or poor capital allocation could further weigh on returns.
This aggregate rating is based on analysts' research of Corteva Inc and is not a guaranteed prediction by Public.com or investment advice.
Corteva Inc (CTVA) Analyst Forecast & Price Prediction
Start investing in Corteva Inc (CTVA)
Order type
Buy in
Order amount
Est. shares
0 shares
FAQs About Corteva Inc (CTVA) Forecast
Corteva Inc (CTVA) Analyst Forecast & Price Prediction
Start investing in Corteva Inc (CTVA)
Order type
Buy in
Order amount
Est. shares
0 shares